Ronald Falk, MD
Ronald Falk, MD is Allan Brewster Distinguished Professor of Medicine at the University of North Carolina-Chapel Hill. He is Chief of the Division of Nephrology and Hypertension and Director of both the UNC Kidney Center and the UNC Solid Organ Transplant Program. He is also Chair of Carolina Dialysis, LLC and Chair and Co-Founder of the Carolina Vascular Access Center. After obtaining his MD from the UNC School of Medicine, Dr. Falk completed a residency in internal medicine and fellowship in nephrology at UNC Hospitals, as well as a research fellowship in pediatric nephrology at the University of Minnesota Hospitals.
Dr. Falk is recognized as an international expert in vasculitis and autoimmune kidney disease. His career as a translational physician-scientist spans nearly three decades, and his practice and basic research focus on characterizing the cell, tissue and physiologic changes in the development of specific autoimmune kidney diseases and developing new approaches for studying autoimmunity, inflammation and basic neutrophil/monocyte biology. His seminal research has been published in the most prestigious scientific and clinical journals, including Nature, Nature Medicine, New England Journal of Medicine, Annals of Internal Medicine, Journal of Clinical Investigation and Proceedings of the National Academy of Science. He conducts extensive research on the identification of biomarkers of kidney disease and currently holds six patents for methods and kits for detecting and monitoring disease biomarkers, as well as two patent applications pending.
Dr. Falk is a Fellow of the American College of Physicians, as well as a Fellow of the American Society of Nephrology (ASN). He has served in various capacities within the ASN, including numerous committees and ASN Council. He served as president from 2011-12 and is the current past president of ASN. He has been actively involved in the national Kidney Health Initiative to advance scientific understanding of the kidney health and safety implications of new and existing medical products and to foster development of therapies for diseases that affect the kidney by creating a collaborative environment in which FDA and the greater nephrology community can interact to optimize evaluation of drugs, devices, biologics and food products. Dr. Falk has been recognized among the “Best Doctors in America” every year since 1992. He resides in Chapel Hill with his family.